View Item 

Show simple item record

Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C‐kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics
dc.contributor.authorCarvalho, Jason Cen_US
dc.contributor.authorWasco, Matthew Jen_US
dc.contributor.authorKunju, Lakshmi Pen_US
dc.contributor.authorThomas, Dafydd Gen_US
dc.contributor.authorShah, Rajal Ben_US
dc.date.accessioned2014-05-23T15:58:56Z
dc.date.available2014-05-23T15:58:56Z
dc.date.issued2011-01en_US
dc.identifier.citationCarvalho, Jason C; Wasco, Matthew J; Kunju, Lakshmi P; Thomas, Dafydd G; Shah, Rajal B (2011). "Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C‐kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics." Histopathology 58(2). <http://hdl.handle.net/2027.42/106819>en_US
dc.identifier.issn0309-0167en_US
dc.identifier.issn1365-2559en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/106819
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherCluster Analysisen_US
dc.subject.otherImmunohistochemistryen_US
dc.subject.otherOncocytomaen_US
dc.subject.otherRenal Cell Carcinomaen_US
dc.titleCluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C‐kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimicsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMicrobiology and Immunologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan Medical Center, Ann Arbor, MIen_US
dc.contributor.affiliationotherDivision of Urologic Pathology, Caris Life Sciences and the Caris Research Institute, Irving, TX, USAen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/106819/1/j.1365-2559.2011.03753.x.pdf
dc.identifier.doi10.1111/j.1365-2559.2011.03753.xen_US
dc.identifier.sourceHistopathologyen_US
dc.identifier.citedreferenceWent P, Dirnhofer S, Salvisberg T et al. Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors. Am. J. Surg. Pathol. 2005; 29; 83 – 88.en_US
dc.identifier.citedreferenceMartignoni G, Pea M, Chilosi M et al. Parvalbumin is constantly expressed in chromophobe renal carcinoma. Mod. Pathol. 2001; 14; 760 – 767.en_US
dc.identifier.citedreferenceMazal PR, Stichenwirth M, Koller A, Blach S, Haitel A, Susani M. Expression of aquaporins and PAX‐2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study. Mod. Pathol. 2005; 18; 535 – 540.en_US
dc.identifier.citedreferencePan CC, Chen PC, Ho DM. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Histopathology 2004; 45; 452 – 459.en_US
dc.identifier.citedreferencePetit A, Castillo M, Santos M, Mellado B, Alcover JB, Mallofre C. KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms. Am. J. Surg. Pathol. 2004; 28; 676 – 678.en_US
dc.identifier.citedreferenceRocca PC, Brunelli M, Gobbo S et al. Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT–PCR study. Mod. Pathol. 2007; 20; 722 – 728.en_US
dc.identifier.citedreferenceSkinnider BF, Folpe AL, Hennigar RA et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am. J. Surg. Pathol. 2005; 29; 747 – 754.en_US
dc.identifier.citedreferenceWang HY, Mills SE. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma. Am. J. Surg. Pathol. 2005; 29; 640 – 646.en_US
dc.identifier.citedreferenceMolinie V, Balaton A, Rotman S et al. Alpha‐methyl CoA racemase expression in renal cell carcinomas. Hum. Pathol. 2006; 37; 69 – 703.en_US
dc.identifier.citedreferenceLangner C, Ratschek M, Rehak P, Schips L, Zigeuner R. Expression of MUC1 (EMA) and E‐cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases. Mod. Pathol. 2004; 17; 180 – 188.en_US
dc.identifier.citedreferenceAllory Y, Bazille C, Vieillefond A et al. Profiling and classification tree applied to renal epithelial tumours. Histopathology 2008; 52; 158 – 166.en_US
dc.identifier.citedreferenceKim SS, Choi YD, Jin XM et al. Immunohistochemical stain for cytokeratin 7, S100A1 and claudin 8 is valuable in differential diagnosis of chromophobe renal cell carcinoma from renal oncocytoma. Histopathology 2009; 54; 633 – 635.en_US
dc.identifier.citedreferenceLiu L, Qian J, Singh H, Meiers I, Zhou X, Bostwick DG. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. Arch. Pathol. Lab. Med. 2007; 131; 1290 – 1297.en_US
dc.identifier.citedreferenceLi G, Gentil‐Perret A, Lambert C, Genin C, Tostain J. S100A1 and KIT gene expressions in common subtypes of renal tumours. Eur. J. Surg. Oncol. 2005; 31; 299 – 303.en_US
dc.identifier.citedreferenceBakshi N, Kunju LP, Giordano T, Shah RB. Expression of renal cell carcinoma antigen (RCC) in renal epithelial and nonrenal tumors: diagnostic Implications. Appl. Immunohistochem. Mol. Morphol. 2007; 15; 310 – 315.en_US
dc.identifier.citedreferenceSkapa P, Hyrsl L, Zavada J, Soukup J, Zamecnik J. Carbonic anhydrase IX expression in clear cell renal cell carcinomas negatively correlates with the proportion of the granular cell component. J. Clin. Oncol. 2008; 26; 3809 – 3811.en_US
dc.identifier.citedreferenceMemeo L, Jhang J, Assaad AM et al. Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma. Am. J. Clin. Pathol. 2007; 127; 225 – 229.en_US
dc.identifier.citedreferenceOzcan A, Zhai J, Hamilton C et al. PAX‐2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney‐specific cadherin. Am. J. Clin. Pathol. 2009; 131; 393 – 404.en_US
dc.identifier.citedreferenceTretiakova MS, Sahoo S, Takahashi M et al. Expression of alpha‐methylacyl‐CoA racemase in papillary renal cell carcinoma. Am. J. Surg. Pathol. 2004; 28; 69 – 76.en_US
dc.identifier.citedreferenceSzponar A, Beothe T, Kovacs G. How useful is alpha‐methylacyl‐CoA racemase (AMACR) immunohistochemistry in the differential diagnosis of kidney cancers? Histopathology 2010; 56; 263 – 265.en_US
dc.identifier.citedreferenceTeratani T, Watanabe T, Kuwahara F et al. Induced transcriptional expression of calcium‐binding protein S100A1 and S100A10 genes in human renal cell carcinoma. Cancer Lett. 2002; 175; 71 – 77.en_US
dc.identifier.citedreferenceMathers ME, Pollock AM, Marsh C, O’Donnell M. Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma. Histopathology 2002; 40; 563 – 567.en_US
dc.identifier.citedreferenceWu SL, Kothari P, Wheeler TM, Reese T, Connelly JH. Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas. Mod. Pathol. 2002; 15; 712 – 717.en_US
dc.identifier.citedreferencePan CC, Chen PC, Chiang H. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma. Am. J. Clin. Pathol. 2004; 121; 878 – 883.en_US
dc.identifier.citedreferenceEble J, Sauter G, Epstein JI et al. WHO classification of tumors: pathology and genetics of tumours of the urinary system and male genital organs. Lyon, France: IARC Press, 2004.en_US
dc.identifier.citedreferenceKunju LP, Wojno K, Wolf JS Jr, Cheng L, Shah RB. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features. Hum. Pathol. 2008; 39; 96 – 101.en_US
dc.identifier.citedreferenceShah RB, Bakshi N, Hafez KS, Wood DP Jr, Kunju LP. Image‐guided biopsy in the evaluation of renal mass lesions in contemporary urological practice: indications, adequacy, clinical impact, and limitations of the pathological diagnosis. Hum. Pathol. 2005; 36; 1309 – 1315.en_US
dc.identifier.citedreferenceCochand‐Priollet B, Molinie V, Bougaran J et al. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases. Arch. Pathol. Lab. Med. 1997; 121; 1081 – 1086.en_US
dc.identifier.citedreferenceTickoo SK, Amin MB, Zarbo RJ. Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: emphasis on technique and patterns of staining. Am. J. Surg. Pathol. 1998; 22; 419 – 424.en_US
dc.identifier.citedreferenceMeyer PN, Cao Y, Jacobson K, Krausz T, Flanigan RC, Picken MM. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)‐facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas. Diagn. Mol. Pathol. 2008; 17; 141 – 144.en_US
dc.identifier.citedreferenceAdley BP, Papavero V, Sugimura J, Teh BT, Yang XJ. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Anal. Quant. Cytol. Histol. 2006; 28; 228 – 236.en_US
dc.identifier.citedreferenceAvery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am. J. Surg. Pathol. 2000; 24; 203 – 210.en_US
dc.identifier.citedreferenceGupta R, Balzer B, Picken M et al. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms. Am. J. Surg. Pathol. 2009; 33; 241 – 247.en_US
dc.identifier.citedreferenceHuo L, Sugimura J, Tretiakova MS et al. C‐kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Hum. Pathol. 2005; 36; 262 – 268.en_US
dc.identifier.citedreferenceLi G, Barthelemy A, Feng G et al. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma. Histopathology 2007; 50; 642 – 647.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2559.2011.03753.x.pdf
Size:
833.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.